Michael Ross
Director/Miembro de la Junta en 20/20 GENESYSTEMS INC. .
Perfil
Michael A.
Ross is currently the Director at 20 and Operating Partner at Havencrest Capital Management LLC.
He is also a Board Member at LarreaRX, Inc. In the past, he served as the President & CEO of Euclid Vision Corp., President and COO of E-P Therapeutics, Inc., and President of CPL, Inc. Dr. Ross received his undergraduate degree from Dickinson College in 1971 and his doctorate from George Washington University School of Medicine & Health in 1975.
Cargos activos de Michael Ross
| Empresas | Cargo | Inicio |
|---|---|---|
| 20/20 GENESYSTEMS INC. | Director/Miembro de la Junta | 01/07/2016 |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Inversor de Capital Privado | 01/04/2020 |
LarreaRX, Inc.
 LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michael Ross.
| Empresas | Cargo | Fin |
|---|---|---|
| E-P Therapeutics, Inc. | Presidente | 01/01/2015 |
CPL, Inc.
 CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | Presidente | 01/10/2009 |
Euclid Vision Corp.
 Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Presidente | - |
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Director Ejecutivo | - |
Formación de Michael Ross.
| Dickinson College | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
20/20 GeneSystems, Inc.
 20/20 GeneSystems, Inc. Medical/Nursing ServicesHealth Services 20/20 GeneSystems, Inc. develops and commercializes proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in 2000 and is headquartered in Rockville, MD. | Health Services |
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Health Technology |
LarreaRX, Inc.
LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Health Technology |
CPL, Inc.
CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | Health Technology |
| E-P Therapeutics, Inc. | |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
- Bolsa de valores
- Insiders
- Michael Ross
